Tag: hepatology
Semaglutide Approved for Advanced Liver Disease: First GLP-1 Drug to Treat MASH with Fibrosis
Semaglutide (Wegovy) has become the first glucagon-like peptide-1 receptor agonist approved to treat metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced liver…
Submit Your Paper to GMJ
No APC until January 2027.